tiprankstipranks
Fate Therapeutics (FATE)
NASDAQ:FATE

Fate Therapeutics (FATE) Balance Sheet

1,095 Followers

Fate Therapeutics Balance Sheet

Fate Therapeutics's total assets for Q4 2023 were $506.22M, a decrease of -6.91% from the previous quarter. FATE total liabilities were $137.80M for the fiscal quarter, a -2.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 506.22M$ 705.56M$ 921.46M$ 622.46M$ 302.27M
Total Liabilities
$ 137.80M$ 221.62M$ 242.62M$ 238.01M$ 57.52M
Total Equity Gross Minority
$ 368.42M$ 483.94M$ 678.84M$ 384.44M$ 244.76M
Total Capitalization
$ 465.78M$ 587.65M$ 678.84M$ 384.44M$ 244.76M
Preferred Stock Equity
---$ 3.00K$ 3.00K
Capital Lease Obligations
---$ 97.30M$ 26.93M
Currency in USD

Fate Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis